Global Acetyl Hexapeptide-3(8) Market Insights, Forecast to 2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 114

Report ID: 19929

Acetyl hexapeptide-3 or acetyl hexapeptide-8 (sources differ) is a synthetic anti-wrinkle cosmetics ingredient. It is a peptide which is a fragment of SNAP-25, a substrate of botulinum toxin (Botox).
The global Acetyl Hexapeptide-3(8) market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Acetyl Hexapeptide-3(8) market based on company, product type, end user and key regions.

This report studies the global market size of Acetyl Hexapeptide-3(8) in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Acetyl Hexapeptide-3(8) in these regions.
This research report categorizes the global Acetyl Hexapeptide-3(8) market by top players/brands, region, type and end user. This report also studies the global Acetyl Hexapeptide-3(8) market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Lipotec
Shanghai Soho-Yiming Pharmaceuticals
Zhejiang Peptites Biotech
Shenzhen JYMed Technology

Acetyl Hexapeptide-3(8) market size by Type
Purity: 98%
Purity: 99%
Other
Acetyl Hexapeptide-3(8) market size by Applications
Pharmaceuticals
Cosmetics & Skin Care

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Acetyl Hexapeptide-3(8) market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Acetyl Hexapeptide-3(8) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Acetyl Hexapeptide-3(8) companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Acetyl Hexapeptide-3(8) submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Acetyl Hexapeptide-3(8) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (Kg). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Acetyl Hexapeptide-3(8) market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Acetyl Hexapeptide-3(8) Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Acetyl Hexapeptide-3(8) Market Size Growth Rate by Type
1.4.2 Purity: 98%
1.4.3 Purity: 99%
1.4.4 Other
1.5 Market by Application
1.5.1 Global Acetyl Hexapeptide-3(8) Market Size Growth Rate by Application
1.5.2 Pharmaceuticals
1.5.3 Cosmetics & Skin Care
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Acetyl Hexapeptide-3(8) Market Size
2.1.1 Global Acetyl Hexapeptide-3(8) Revenue 2014-2025
2.1.2 Global Acetyl Hexapeptide-3(8) Sales 2014-2025
2.2 Acetyl Hexapeptide-3(8) Growth Rate by Regions
2.2.1 Global Acetyl Hexapeptide-3(8) Sales by Regions
2.2.2 Global Acetyl Hexapeptide-3(8) Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Acetyl Hexapeptide-3(8) Sales by Manufacturers
3.1.1 Acetyl Hexapeptide-3(8) Sales by Manufacturers
3.1.2 Acetyl Hexapeptide-3(8) Sales Market Share by Manufacturers
3.2 Acetyl Hexapeptide-3(8) Revenue by Manufacturers
3.2.1 Acetyl Hexapeptide-3(8) Revenue by Manufacturers (2014-2019)
3.2.2 Acetyl Hexapeptide-3(8) Revenue Share by Manufacturers (2014-2019)
3.3 Acetyl Hexapeptide-3(8) Price by Manufacturers
3.4 Acetyl Hexapeptide-3(8) Manufacturing Base Distribution, Product Types
3.4.1 Acetyl Hexapeptide-3(8) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Acetyl Hexapeptide-3(8) Product Type
3.4.3 Date of International Manufacturers Enter into Acetyl Hexapeptide-3(8) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Acetyl Hexapeptide-3(8) Sales by Type
4.2 Global Acetyl Hexapeptide-3(8) Revenue by Type
4.3 Acetyl Hexapeptide-3(8) Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Acetyl Hexapeptide-3(8) Breakdown Data by Application

6 North America
6.1 North America Acetyl Hexapeptide-3(8) by Country
6.1.1 North America Acetyl Hexapeptide-3(8) Sales by Country
6.1.2 North America Acetyl Hexapeptide-3(8) Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Acetyl Hexapeptide-3(8) by Type
6.3 North America Acetyl Hexapeptide-3(8) by Application

7 Europe
7.1 Europe Acetyl Hexapeptide-3(8) by Country
7.1.1 Europe Acetyl Hexapeptide-3(8) Sales by Country
7.1.2 Europe Acetyl Hexapeptide-3(8) Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Acetyl Hexapeptide-3(8) by Type
7.3 Europe Acetyl Hexapeptide-3(8) by Application

8 Asia Pacific
8.1 Asia Pacific Acetyl Hexapeptide-3(8) by Country
8.1.1 Asia Pacific Acetyl Hexapeptide-3(8) Sales by Country
8.1.2 Asia Pacific Acetyl Hexapeptide-3(8) Revenue by Country
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Acetyl Hexapeptide-3(8) by Type
8.3 Asia Pacific Acetyl Hexapeptide-3(8) by Application

9 Central & South America
9.1 Central & South America Acetyl Hexapeptide-3(8) by Country
9.1.1 Central & South America Acetyl Hexapeptide-3(8) Sales by Country
9.1.2 Central & South America Acetyl Hexapeptide-3(8) Revenue by Country
9.1.3 Brazil
9.1.4 Argentina
9.2 Central & South America Acetyl Hexapeptide-3(8) by Type
9.3 Central & South America Acetyl Hexapeptide-3(8) by Application

10 Middle East and Africa
10.1 Middle East and Africa Acetyl Hexapeptide-3(8) by Country
10.1.1 Middle East and Africa Acetyl Hexapeptide-3(8) Sales by Country
10.1.2 Middle East and Africa Acetyl Hexapeptide-3(8) Revenue by Country
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Acetyl Hexapeptide-3(8) by Type
10.3 Middle East and Africa Acetyl Hexapeptide-3(8) by Application

11 Company Profiles
11.1 Lipotec
11.1.1 Lipotec Company Details
11.1.2 Company Business Overview
11.1.3 Lipotec Acetyl Hexapeptide-3(8) Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Lipotec Acetyl Hexapeptide-3(8) Products Offered
11.1.5 Lipotec Recent Development
11.2 Shanghai Soho-Yiming Pharmaceuticals
11.2.1 Shanghai Soho-Yiming Pharmaceuticals Company Details
11.2.2 Company Business Overview
11.2.3 Shanghai Soho-Yiming Pharmaceuticals Acetyl Hexapeptide-3(8) Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Shanghai Soho-Yiming Pharmaceuticals Acetyl Hexapeptide-3(8) Products Offered
11.2.5 Shanghai Soho-Yiming Pharmaceuticals Recent Development
11.3 Zhejiang Peptites Biotech
11.3.1 Zhejiang Peptites Biotech Company Details
11.3.2 Company Business Overview
11.3.3 Zhejiang Peptites Biotech Acetyl Hexapeptide-3(8) Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Zhejiang Peptites Biotech Acetyl Hexapeptide-3(8) Products Offered
11.3.5 Zhejiang Peptites Biotech Recent Development
11.4 Shenzhen JYMed Technology
11.4.1 Shenzhen JYMed Technology Company Details
11.4.2 Company Business Overview
11.4.3 Shenzhen JYMed Technology Acetyl Hexapeptide-3(8) Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Shenzhen JYMed Technology Acetyl Hexapeptide-3(8) Products Offered
11.4.5 Shenzhen JYMed Technology Recent Development

12 Future Forecast
12.1 Acetyl Hexapeptide-3(8) Market Forecast by Regions
12.1.1 Global Acetyl Hexapeptide-3(8) Sales Forecast by Regions 2019-2025
12.1.2 Global Acetyl Hexapeptide-3(8) Revenue Forecast by Regions 2019-2025
12.2 Acetyl Hexapeptide-3(8) Market Forecast by Type
12.2.1 Global Acetyl Hexapeptide-3(8) Sales Forecast by Type 2019-2025
12.2.2 Global Acetyl Hexapeptide-3(8) Revenue Forecast by Type 2019-2025
12.3 Acetyl Hexapeptide-3(8) Market Forecast by Application
12.4 North America Acetyl Hexapeptide-3(8) Forecast
12.5 Europe Acetyl Hexapeptide-3(8) Forecast
12.6 Asia Pacific Acetyl Hexapeptide-3(8) Forecast
12.7 Central & South America Acetyl Hexapeptide-3(8) Forecast
12.8 Middle East and Africa Acetyl Hexapeptide-3(8) Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Acetyl Hexapeptide-3(8) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer